Effect of epidermal growth factor on the fetal development of the tracheobronchial secretory apparatus in rhesus monkey.
Effect of epidermal growth factor on the fetal development of the tracheobronchial secretory apparatus in rhesus monkey.
复制标题
表皮生长因子对恒河猴气管支气管分泌器胎儿发育的影响。
DOI:
10.1165/ajrcmb/4.2.95
复制
发表时间:
1991
影响因子:
6.4
通讯作者:
Plopper,CG
中科院分区:
文献类型:
--
作者:
StGeorge,JA;Read,LC;Cranz,DL;Tarantal,AF;George-Nascimento,C;Plopper,CG
Fetal rhesus monkeys were treated with recombinant human epidermal growth factor (EGF) to determine if EGF can induce maturation of the tracheobronchial secretory apparatus. At 75% of gestation, EGF was administered simultaneously into both the amniotic fluid and fetal abdominal cavity at an average dose of 66 I-tg/kg body weight, by each route over a 7-d period. At the end of the treatment period, the fetuses were delivered and either euthanized immediately or after maintenance on ventilatory support for 6 h. The lungs were removed, and the trachea and one lobe of the right lung was fixed and embedded for light microscopy. The left lung was lavaged with saline, and the collected fluid was used to quantify released secretory product. Secretory product was also measured in amniotic fluid as well as in situ on histologic sections of tracheal epithelium. When the tracheas of EGF-treated monkeys were examined, the epithelium was found to be taller and to contain a greater proportion of secretory cells and a smaller proportion of intermediate cells than the control group. However, there was no significant change in the total number of cells per millimeter of basal lamina or in the proportion of the epithelial population made up of basal or ciliated cells. There was more secretory product stored in the epithelium and submucosal glands and increased quantities of respiratory secretions in both lung lavage and amniotic fluid of EGF-treated monkeys. We conclude that EGF treatment accelerates differentiation of tracheal mucous secretory cells, based on a marked increase in both the number of cells with secretory granules and in the amount of secretory product released into the airway lumen. EGF treatment did not, however, stimulate epithelial proliferation when administered in the third trimester, when the trachea is actively differentiating.Fetal lung development is accelerated by an assortment of hormones and growth factors (1). The majority of the literature on lung development and the factors affecting it have focused on the regulation of growth and differentiation of the pulmonary gas exchange area rather than the tracheobronchial conducting airways. It has not been demonstrated that substances shown to affect the development of the gas exchange area would similarly affect the tracheobronchial tree. For example, glucocorticoids, thyroid hormone, cyclic AMP, and epidermal growth factor (EGF) have been shown to stimulate growth and maturation of the gas exchange area (1-3), but the effectsof these substances in tracheobronchial maturation have not been well characterized. EGF is a poly-